The Biden Administration announced, on August 29, the first ten prescription drugs that will be subject to Medicare price negotiations. The Inflation Reduction Act allows the Medicare Drug Price Negotiation Program to work directly with drug manufacturers to improve the affordability of high-cost name-brand drugs. The ten Medicare Part D …